Phase 2, Multi-center, Randomized, Double- Masked and Placebo-Controlled Study of YP-P10 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (ICECAP 1)
Public ClinicalTrials.gov record NCT05467293. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multi-center, Randomized, Double- Masked and Placebo-Controlled Study Evaluating the Efficacy and Safety of YP-P10 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (ICECAP 1)
Study identification
- NCT ID
- NCT05467293
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Yuyu Pharma, Inc.
- Industry
- Enrollment
- 257 participants
Conditions and interventions
Conditions
Interventions
- 0.3% YP-P10 Ophthalmic Solution Drug
- 1% YP-P10 Ophthalmic Solution Drug
- YP-P10 Placebo Ophthalmic Solution (vehicle) Drug
Drug
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 26, 2022
- Primary completion
- Mar 5, 2023
- Completion
- Mar 5, 2023
- Last update posted
- Jul 29, 2024
2022 – 2023
United States locations
- U.S. sites
- 7
- U.S. states
- 6
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cornea Consultants of Arizona | Phoenix | Arizona | 85032 | — |
| Aesthetic Eye Care Institute | Newport Beach | California | 92663 | — |
| Vision Institute | Colorado Springs | Colorado | 80907 | — |
| Andover Eye Associates | Andover | Massachusetts | 01810 | — |
| NC Eye Associates | Apex | North Carolina | 27502 | — |
| Oculus Research | Garner | North Carolina | 27529 | — |
| Total Eye Care | Memphis | Tennessee | 38119 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05467293, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 29, 2024 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05467293 live on ClinicalTrials.gov.